The present invention relates to a biomarker and method for identifying the subgroup of early stage lung adenocarcinoma patients in early stage NSCLC, which is helpful for {HEAD ~ the design} of {TAIL ~ clinical trials} for adjuvant therapy 
of
The present invention relates to a biomarker and method for identifying the subgroup of early stage lung adenocarcinoma patients in early stage NSCLC , which is helpful for { HEAD ~ the design } of { TAIL ~ clinical trials } for adjuvant therapy
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH